Skip to content

2nd Annual Genotoxic Impurities in Pharmaceuticals Virtual Conference 2021

Calendar icon to

Proudly supported by


Carla Landolfi, ERT

European Registered Toxicologist (ERT) CEO - Toxicology Risk Assessor | ToxHub Srl, IT

Raphy Nudelman

Director, Chemical & Computational Toxicology | Teva Pharmaceutical Industries Ltd., IL

Mark Harrison

Principal Analyst | AstraZeneca, UK

David Lovell

Reader in Medical Statistics | St. George’s University, UK

Abby Myhre

Technical Lead | Corteva, USA

Joerg Freudenberger

Manager Strategy & Global Business Development | Intertek (Schweiz) AG, CH

Tom van Wijk

Principal Scientist, Analytical Science and Technology Team lead Pharmaceutical analysis | Abbott Healthcare Products

Ron Brown

Owner and Principal Toxicologist | Risk Science Consortium, LLC

Michael Burns

Principal Research Scientist at Lhasa Limited, UK

Margaret Maziarz

Principal Scientist, Scientific Operations | Waters Corporation, USA

Daniel Roberts

Genetic Toxicologist and Flow Cytometrist | Charles River Laboratories, USA

David Kirkland

Genetox Consultant | Kirkland Consulting, UK

Carol Beevers

Managing Scientist | Exponent International Ltd, UK

Stephen Dertinger

Director of Research | Litron Laboratories, Rochester, USA

Michelle Kenyon

Associate research fellow in Drug Safety | Pfizer Global Research and Development, USA

Mike Urquhart

Scientific Director | GlaxoSmithKline, UK

Rachael Tennant

Senior Research Scientist | Lhasa Limited, UK

Vimal Sachdeva

Technical Officer (Expert Inspector) | World Health Organization (WHO), CH

george johnson

Associate Professor in the Institute of Life Science | Swansea University, UK

The event is over

Hosted by


Share on